TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes

Bleeding is a risk of potent antiplatelet therapy. Anemia is associated with increased bleeding. We sought to examine the rates of prasugrel use, thienopyridine switching and clinical outcomes by presence of anemia in contemporary percutaneous coronary intervention (PCI) for acute coronary syndrome